Back to top
more

Avantor (AVTR)

(Real Time Quote from BATS)

$11.30 USD

11.30
5,111,449

-0.34 (-2.92%)

Updated Aug 6, 2025 02:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (73 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

New Strong Sell Stocks for February 20th

by Zacks Equity Research

HAFC, AVTR and WHD have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.

Zacks Equity Research

Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down

by Zacks Equity Research

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.

Zacks Equity Research

Compared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Curious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Avantor, Inc. (AVTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

Zacks Equity Research

ELV vs. AVTR: Which Stock Is the Better Value Option?

by Zacks Equity Research

ELV vs. AVTR: Which Stock Is the Better Value Option?

Zacks Equity Research

Viatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite

by Zacks Equity Research

Avantor's (AVTR) latest offerings are likely to provide its customers with products, materials and services that would aid in accelerating therapeutics.

Zacks Equity Research

Avantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top

by Zacks Equity Research

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft third-quarter performance.

Zacks Equity Research

Compared to Estimates, Avantor, Inc. (AVTR) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates

by Zacks Equity Research

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 0% and 1.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Revvity's (RVTY) New Launch to Widen Access to Editing Technology

by Zacks Equity Research

Revvity's (RVTY) latest offering is likely to improve access to new-generation editing technology and bridge both preclinical and clinical discoveries with the same technology platform.

Zacks Equity Research

Alignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Avantor's (AVTR) Tie-Up to Address Temperature-Specific Logistics

by Zacks Equity Research

Avantor's (AVTR) partnership is likely to meet the growing need among biopharma and life science companies for end-to-end solutions.

Zacks Equity Research

New Strong Sell Stocks for September 11th

by Zacks Equity Research

AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.

Zacks Equity Research

Charles River (CRL) Down 6.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Why Is Viatris (VTRS) Down 4.8% Since Last Earnings Report?

by Zacks Equity Research

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Revvity (RVTY) Down 4.9% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Revvity (RVTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

New Strong Sell Stocks for August 22nd

by Zacks Equity Research

AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.

Zacks Equity Research

Avantor (AVTR) Q2 Earnings Lag Estimates, FY23 View Revised

by Zacks Equity Research

Despite Avantor's (AVTR) strength in end markets, it reports an overall soft second-quarter performance.

Zacks Equity Research

Here's What Key Metrics Tell Us About Avantor, Inc. (AVTR) Q2 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Avantor, Inc. (AVTR) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Avantor, Inc. (AVTR) Misses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of -3.45% and 3.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Avantor, Inc. (AVTR) Soars 6.7%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Avantor, Inc. (AVTR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Avantor's (AVTR) New Expansion Plans to Boost Workflow

by Zacks Equity Research

Avantor's (AVTR) latest expansion plans are likely to aid customers in creating customized workflow solutions.

Zacks Equity Research

Strength Seen in Bright Health (BHG): Can Its 11.9% Jump Turn into More Strength?

by Zacks Equity Research

Bright Health (BHG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.